Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Anne Marie Desbois"'
Autor:
Anuja Chatterjee, Gijs van de Wetering, Ron Goeree, Carolyn Owen, Anne Marie Desbois, Stephane Barakat, Beenish S. Manzoor, Kavita Sail
Publikováno v:
PharmacoEconomics - Open. 7:199-216
Venetoclax is a first-in-class targeted therapy option that is an inducer of apoptosis in chronic lymphocytic leukemia (CLL) cells. The open-label phase III CLL14 clinical trial showed that venetoclax combined with obinutuzumab (VEN+O) is superior to
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::83a5bfbc149f687a769b285181c785f3
https://doi.org/10.1007/s41669-022-00375-x
https://doi.org/10.1007/s41669-022-00375-x
Autor:
Beenish S Manzoor, Patricia Manzi, Gijs van de Wetering, Anne Marie Desbois, Kavita Sail, Ron Goeree, Carolyn Owen, Anuja Chatterjee
Publikováno v:
Blood. 136:31-32
OBJECTIVES: To estimate the cost-effectiveness of venetoclax + obinutuzumab (GAZYVA®, G), (VEN+G) in the treatment of first-line (1L) chronic lymphocytic leukemia (CLL) from a Canadian health care system cost perspective. METHODS: A three-state part
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::fbc433a291f568cb0c861f5fe608544a
https://doi.org/10.1182/blood-2020-134596
https://doi.org/10.1182/blood-2020-134596